首页 > 最新文献

B45. COPD: TREATMENT最新文献

英文 中文
Pharmacokinetics and Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate in Adults with Moderate-to-Severe Chronic Obstructive Pulmonary Disease: A Phase I, Open-Label, Single-Center Study 布地奈德/甘罗罗酸酯/富马酸福莫特罗用于成人中重度慢性阻塞性肺疾病的药代动力学和安全性:一项I期、开放标签、单中心研究
Pub Date : 2019-05-01 DOI: 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3321
P. Dorinsky, L. Dunn, K. DeAngelis, Mindy Mo, M. Gillen
{"title":"Pharmacokinetics and Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate in Adults with Moderate-to-Severe Chronic Obstructive Pulmonary Disease: A Phase I, Open-Label, Single-Center Study","authors":"P. Dorinsky, L. Dunn, K. DeAngelis, Mindy Mo, M. Gillen","doi":"10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3321","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3321","url":null,"abstract":"","PeriodicalId":311626,"journal":{"name":"B45. COPD: TREATMENT","volume":"95 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131543819","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictors of Empiric Treatment in Smokers with Normal Spirometry 肺活量正常的吸烟者经验性治疗的预测因素
Pub Date : 2019-05-01 DOI: 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3306
N. Arnold, C. Hersh, E. Wan, G. Kinney, K. Young, J. Hokanson, E. Regan, A. Comellas, S. Fortis
{"title":"Predictors of Empiric Treatment in Smokers with Normal Spirometry","authors":"N. Arnold, C. Hersh, E. Wan, G. Kinney, K. Young, J. Hokanson, E. Regan, A. Comellas, S. Fortis","doi":"10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3306","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3306","url":null,"abstract":"","PeriodicalId":311626,"journal":{"name":"B45. COPD: TREATMENT","volume":"223 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132701359","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prescription Tendencies and Clinical Outcomes of ICS for Management of COPD, A 'Real World' Review ICS治疗慢性阻塞性肺病的处方倾向和临床结果,“真实世界”综述
Pub Date : 2019-05-01 DOI: 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3353
G. Rampon, M. Reddy, S. Burke, L. Bushmann, S. Patolia, E. Charbek
{"title":"Prescription Tendencies and Clinical Outcomes of ICS for Management of COPD, A 'Real World' Review","authors":"G. Rampon, M. Reddy, S. Burke, L. Bushmann, S. Patolia, E. Charbek","doi":"10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3353","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3353","url":null,"abstract":"","PeriodicalId":311626,"journal":{"name":"B45. COPD: TREATMENT","volume":"396 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125158047","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is Triple Therapy in a Single MDI Inhaler Superior to Standard Treatment in Patients with Stable COPD? A 6 Month Prospective Cohort Crossover Study with Patients Acting as Their Own Controls 稳定期COPD患者单MDI吸入器三联治疗优于标准治疗吗?一项为期6个月的前瞻性队列交叉研究,患者作为自己的对照
Pub Date : 2019-05-01 DOI: 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3335
S. Rustscheff
{"title":"Is Triple Therapy in a Single MDI Inhaler Superior to Standard Treatment in Patients with Stable COPD? A 6 Month Prospective Cohort Crossover Study with Patients Acting as Their Own Controls","authors":"S. Rustscheff","doi":"10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3335","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3335","url":null,"abstract":"","PeriodicalId":311626,"journal":{"name":"B45. COPD: TREATMENT","volume":"2014 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127487806","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Benefits of Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (GFF MDI) in Symptomatic Patients with COPD: A Post-Hoc Analysis from a Phase III, Randomized, Placebo-Controlled Study (PINNACLE-4) 甘罗酸/富马酸福莫特罗计量吸入器(GFF MDI)对有症状的COPD患者的益处:来自III期随机安慰剂对照研究(PINNACLE-4)的事后分析
Pub Date : 2019-05-01 DOI: 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3342
B. Lipworth, David J. Collier, G. Feldman, S. Arora, M. Jenkins, C. Reisner, U. Martin
{"title":"Benefits of Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (GFF MDI) in Symptomatic Patients with COPD: A Post-Hoc Analysis from a Phase III, Randomized, Placebo-Controlled Study (PINNACLE-4)","authors":"B. Lipworth, David J. Collier, G. Feldman, S. Arora, M. Jenkins, C. Reisner, U. Martin","doi":"10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3342","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3342","url":null,"abstract":"","PeriodicalId":311626,"journal":{"name":"B45. COPD: TREATMENT","volume":"46 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133205977","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Performance of Contemporary Portable Oxygen Concentrators Across Diverse Breathing Behaviours 当代便携式氧气浓缩器在不同呼吸行为下的性能
Pub Date : 2019-05-01 DOI: 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3343
D. Martin, T. Cheng, M. Su, R. Bertinato
{"title":"Performance of Contemporary Portable Oxygen Concentrators Across Diverse Breathing Behaviours","authors":"D. Martin, T. Cheng, M. Su, R. Bertinato","doi":"10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3343","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3343","url":null,"abstract":"","PeriodicalId":311626,"journal":{"name":"B45. COPD: TREATMENT","volume":"6 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130923518","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative Real-World Effectiveness of Triple Therapy Versus Dual Bronchodilation on Lung Function Decline in Frequently Exacerbating Patients with COPD 三联治疗与双重支气管扩张对慢性阻塞性肺病频繁加重患者肺功能下降的实际疗效比较
Pub Date : 2019-05-01 DOI: 10.1164/AJRCCM-CONFERENCE.2019.199.1_MEETINGABSTRACTS.A3314
J. Voorham, M. Kerkhof, G. Georges, S. Vezzoli, A. Papi, C. Vogelmeier, D. Singh, L. Fabbri, J. Kocks, D. Price
{"title":"Comparative Real-World Effectiveness of Triple Therapy Versus Dual Bronchodilation on Lung Function Decline in Frequently Exacerbating Patients with COPD","authors":"J. Voorham, M. Kerkhof, G. Georges, S. Vezzoli, A. Papi, C. Vogelmeier, D. Singh, L. Fabbri, J. Kocks, D. Price","doi":"10.1164/AJRCCM-CONFERENCE.2019.199.1_MEETINGABSTRACTS.A3314","DOIUrl":"https://doi.org/10.1164/AJRCCM-CONFERENCE.2019.199.1_MEETINGABSTRACTS.A3314","url":null,"abstract":"","PeriodicalId":311626,"journal":{"name":"B45. COPD: TREATMENT","volume":"56 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121858183","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Effect of Age on Efficacy and Safety of Multiple Inhaler Triple Therapy with Umeclidinium Added to Fluticasone Furoate/Vilanterol in Chronic Obstructive Pulmonary Disease 年龄对Umeclidinium联合糠酸氟替卡松/维兰特罗治疗慢性阻塞性肺疾病疗效和安全性的影响
Pub Date : 2019-05-01 DOI: 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3326
T. Soule, S. Caveney, L. Tombs, I. Boucot
{"title":"Effect of Age on Efficacy and Safety of Multiple Inhaler Triple Therapy with Umeclidinium Added to Fluticasone Furoate/Vilanterol in Chronic Obstructive Pulmonary Disease","authors":"T. Soule, S. Caveney, L. Tombs, I. Boucot","doi":"10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3326","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3326","url":null,"abstract":"","PeriodicalId":311626,"journal":{"name":"B45. COPD: TREATMENT","volume":"28 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121481498","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative Efficacy and Safety of Umeclidinium/Vilanterol, Umeclidinium and Salmeterol in Symptomatic Maintenance-Naïve and Maintenance-Treated Chronic Obstructive Pulmonary Disease: A Pre-Specified Secondary Analysis of the EMAX Trial Umeclidinium/Vilanterol, Umeclidinium和沙美特罗在症状性Maintenance-Naïve和维持治疗的慢性阻塞性肺疾病中的比较疗效和安全性:EMAX试验的预先指定的次要分析
Pub Date : 2019-05-01 DOI: 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3317
L. Bjermer, E. Kerwin, F. Maltais, P. Jones, I. Boucot, L. Tombs, I. Naya, M. Watkins, David A. Lipson, C. Compton, C. Vogelmeier
{"title":"Comparative Efficacy and Safety of Umeclidinium/Vilanterol, Umeclidinium and Salmeterol in Symptomatic Maintenance-Naïve and Maintenance-Treated Chronic Obstructive Pulmonary Disease: A Pre-Specified Secondary Analysis of the EMAX Trial","authors":"L. Bjermer, E. Kerwin, F. Maltais, P. Jones, I. Boucot, L. Tombs, I. Naya, M. Watkins, David A. Lipson, C. Compton, C. Vogelmeier","doi":"10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3317","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3317","url":null,"abstract":"","PeriodicalId":311626,"journal":{"name":"B45. COPD: TREATMENT","volume":"6 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131372508","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Preventing Clinically Important Deterioration with Umeclidinium/Vilanterol Versus Bronchodilator Monotherapy in Patients with Chronic Obstructive Pulmonary Disease Free of Inhaled Corticosteroids: A Prospective Analysis of the EMAX Trial 在无吸入皮质类固醇的慢性阻塞性肺疾病患者中,乌莫替尼/维兰特罗与支气管扩张剂单药治疗预防临床重要恶化:EMAX试验的前瞻性分析
Pub Date : 2019-05-01 DOI: 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3315
C. Vogelmeier, F. Maltais, E. Kerwin, L. Bjermer, I. Naya, L. Tombs, I. Boucot, M. Watkins, David A. Lipson, C. Compton, P. Jones
{"title":"Preventing Clinically Important Deterioration with Umeclidinium/Vilanterol Versus Bronchodilator Monotherapy in Patients with Chronic Obstructive Pulmonary Disease Free of Inhaled Corticosteroids: A Prospective Analysis of the EMAX Trial","authors":"C. Vogelmeier, F. Maltais, E. Kerwin, L. Bjermer, I. Naya, L. Tombs, I. Boucot, M. Watkins, David A. Lipson, C. Compton, P. Jones","doi":"10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3315","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3315","url":null,"abstract":"","PeriodicalId":311626,"journal":{"name":"B45. COPD: TREATMENT","volume":"21 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114655408","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
B45. COPD: TREATMENT
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1